The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Jan. 10, 2017
Applicants:

Universitat Autonoma DE Barcelona, Barcelona, ES;

Institut Recerca Hospital DE LA Santa Creu I Sant Pau, Barcelona, ES;

Centro DE Investigacion Biomedica En Red En Bioingenieria, Biomateriales Y Nanomedicina (Ciber Bbn), Zaragoza, ES;

Inventors:

Antonio Pedro Villaverde Corrales, Barcelona, ES;

Esther Vazquez Gomez, Barcelona, ES;

Maria Virtudes Cespedes Navarro, Zaragoza, ES;

Isolda Casanova Rigat, Zaragoza, ES;

Neus Ferrer Miralles, Barcelona, ES;

Ramon Mangues Bafalluy, Barcelona, ES;

Ugutz Unzueta Elorza, Barcelona, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 47/00 (2006.01); C07K 7/08 (2006.01); C07K 14/00 (2006.01); C12N 15/62 (2006.01); C12N 15/86 (2006.01); C07K 14/435 (2006.01); A61K 47/62 (2017.01); A61K 47/66 (2017.01);
U.S. Cl.
CPC ...
A61K 38/10 (2013.01); A61K 47/62 (2017.08); A61K 47/66 (2017.08); C07K 7/08 (2013.01); C07K 14/00 (2013.01); C07K 14/43504 (2013.01); C12N 15/62 (2013.01);
Abstract

Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided. Therapeutic and diagnostic methods with the conjugates which require specific targeting to CXCR4+ cells are provided as well.


Find Patent Forward Citations

Loading…